Investigation of cochleates as carriers for topical drug delivery

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue 2, 2013, Pages 314-320

  Landge, Anuprita ^a   Pawar, Atmaram ^a   Shaikha, Karimunnis ^a,b  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b Affiliated to Savitribai Phule Pune University   (India)

Author keywords

Antifungal; Cochleate; Factorial design; Lipidic; Liposome; Skin deposition; Topical; Vesicular

Indexed keywords

COCHLEATE; DRUG CARRIER; KETOCONAZOLE; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; FACTORIAL DESIGN; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; NONHUMAN; PARTICLE SIZE; TOPICAL TREATMENT;

EID: 84875941925     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Zasadzinski J. Novel approaches to lipid based delivery system. Curr Opin Solid St M 1997; 2: 345-349.
2. Gelbart W. The new science of complex fluids. J Phys Chem 1996; Vol. 100: 13169-13189.
3. Ganesan, M, Weiner N, Flynn G, Ho N. Influence of liposomal drug entrapment on percutaneous absorption. Int J Pharm 1984; Vol. 20: 139-154.
4. Mezei M and Gulasekharam V. Liposomes-A selective drug delivery system for the topical route administration. I. Lotion dosage forms. Life Sci 1980; Vol. 26: 1473-1477.
5. Mezei M and Gulasekharam V. Liposomes-A selective drug delivery system for the topical route of administration: Gel dosage form. J Pharm Pharmacol 1982; Vol. 34: 473-477.
6. Silvander M, Ringstad L, Ghadially R, Sköld T. A new water-based topical carrier with polar skin-lipids. Lipids Health Dis 2006; Vol. 5: 12.
7. Maghraby El, Williams GM, Barry AC. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm 2000; Vol. 196: 63-74.
8. Shaikh KS, Pawar AP. Liposomal delivery enhances cutaneous availability of ciclopirox olamine. Lat Am J Pharm 2009; 29(5): 763-70.
9. Shaikh KS, Bothiraja C, Pawar AP. Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine. Drug Dev Ind Pharm 2010; Vol. 36(8): 946-953.
10. Papahadjopoulos D, Vail WJ, Jacobson K, Poste G. Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles. Biochim Biophys Acta 1975; Vol. 394: 483-491.
11. Zarif L, Jin T, Segarra I, Mannino R. Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules, European Patent Specification, 2000; EP 1 143 933 B1.
12. Syed UM, Woo AF, Plakogiannis F, Jin T, Zhuc H. Cochleates bridged by drug molecules. Int J Pharm 2008; Vol. 363: 118-125.
13. Delmarre D, Gould-Fogerite S, Mannino RJ. Formulation of Hydrophobic Drugs into Cochleate Delivery Vehicles: A Simplified Protocol & BioralTM Formulation Kit. Drug Delivery Technology 2004; Vol. 4: No.1.
14. Helens H, Bentz J. pH induced destabilization of phosphatidyl ethanolamine containing liposomes. Biochem 1984; Vol. 23: 1532-1538.
15. Lu D, Huang L. Small but not large unilamellar liposomes composed of dioleoylphoshatidyl ethanolamine and oleic acid. Biochem 1989; Vol. 28: 7700-7707.
16. Torchilin VP, Klibanov AL. Coupling of ligands with liposomal membranes. Drug Target Del 1993; Vol. 2: 227-238.
17. Gabizon A, Papahadjopoulos D. Liposomes formulation with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U.S. A 1998; Vol. 85: 6949-6953.
18. Drummonds DC, Zignanai M. Current status of pH sensitive Liposomes in Drug Delivery. Prog Lipid Res 2000; Vol. 39: 409-460.
19. Leroux J, Roux E, Garrec DL, Hong K. N-Isopropyl acramide co-polymers for the preparation of pH sensitive liposomes and polymeric micelles. J Control Rel 2001; Vol. 72: 71-84.
20. Turk MJ, Reddy JA, Chmielewiski JA, Low PS. Characterization of a novel pH sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pH. Biochim Biophys Acta 2002; Vol. 1559: 56-68.
21. Feng SS, Ruan G, Li Q. Fabrication and characterization of novel drug delivery device liposomes in microspheres (LIMs). Biomaterials 2004; Vol. 25: 5181-5189.
22. Kumar A, Badde S, Kamble R, Pokharkar VB. Development and characterization of liposomal drug delivery system for nimesulide. Int J Pharmacy Pharm Sci 2010; Vol. 10 (4):87-89.
23. Rao GU, Murthy R, Marfatia YS, Shankar R. Influence of liposomal drug entrapment on the performance of corticosteroid creams. Indian J Dermatol Venereol Leprol 1994; Vol. 60: 5-7.
24. Setha AK, Misrab A. Preparation and Evaluation of Acyclovir Liposomes by Two Techniques: A Comparative Study. J Pharm Res 2007; Vol. 6(2): 75-81.
25. Glavas DM, Simonoska M, Goracinova K. Formulation and characterization of topical liposome gel bearing lidocaine HCl. Bulletin of the Chemists and Technologists of Macedonia 2005; Vol. 24(1): 59-65.
26. Qi XR, Liu MH, Liu HY, Maitani Y, Nagai T. Topical econazole delivery using liposomal gel. STP Pharma Sci 2003; Vol. 13(4): 241-245.
27. Esclusa-Diaz MT, Guimaraens-Mfndez M, Pfrez-Marcos MB, Vila-Jato JL, Torres-Labandeira JJ. 'Characterization and in vitro dissolution behavior of ketoconazole/β-and 2-hydroxypropyl-β-cyclodextrin inclusion compounds. Int J Pharm 1996; Vol. 143(2): 203-210.
28. Najmuddin M, Mohsin AA, Khan T, Patel V, Shelar S. Formulation and evaluation of solid dispersion incorporated gel of ketoconazole. Research Journal of Pharmaceutical, Biological and Chemical Sciences 2010; Vol. 1(2): 406-412.
29. Patel RP, Ashok HP, Baria H. Formulation and Evaluation of Liposomes of Ketoconazole. Int J Drug Delivery Technology 2009; Vol. 1(1): 16-23.
30. Arora R, Sharma A. Release Studies of Ketoconazole niosome formulation. J Global Pharma Technology 2010; Vol.2(1): 125-127.
31. Pandey S, Devmurari V, Goyani M, Pandey D. Formulation, optimization and in-vitro evaluation of ketoconazole cream. Der Pharmacia Lettre 2009; Vol.1(2): 8-24.
32. Najmuddin M, Khan T, Mohsin AA, Shelar S, Patel V. Enhancement of dissolution rate of ketoconazole by solid dispersion. Int J Pharmacy Pharm Sci 2010; Vol. 2 (3): 132-137.
33. Marone PA, Elsmore SK, Sandulow J, Mannino RJ. Structural determinants of divalent cation-Induced phosphatidylserine cochleate crystallization. Microscopy and Microanalysis 2005; Vol. 11(2): 1244-1245.
34. Zarif L. Cochleates as Nanoparticular Drug Carriers In: Torchilin, V. P. Nanoparticulates as drug carriers. 2006; 349-366, London: Imperial College Press.
35. Jin T, Zarif L, Raphael M. Nanocochleate formulations process of preparation and method of delivery of pharmaceutical agents. 2000; US Patents 6,153,217.
36. ++binding to phosphatidylserine vesicles and resultant phase changes of bilayer membrane structure. Biochim Biophys Acta 1978; Vol. 506(2): 281-287.
37. Zarif L. Drug Delivery by Lipid Cochleates, In: Düzgünes, N. Methods in enzymology, Liposomes, Part E. UK:Academic Press; 2005 Vol. 391: 314-329.